7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR
September 25-26, 2017 Chicago, Illinois, USA

Upcoming Conference

Home seperator ABOUT seperator OPEN ACCESS seperator CONFERENCES seperator JOURNALS seperator FAQs seperator CONTACT
Regulatory Affairs 2017
Home
Gallery
Regulatory Affairs 2017 Report

Regulatory Affairs 2017

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR was held during September 25-26, 2017 at Doubletree by Hilton Hotel Chicago, Illinois, USA. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Regulatory professionals, scientists, academicians representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Regulatory Challenges and Implications” which included the following scientific tracks:  

Regulatory Affairs

Regulatory & Pharmacovigilance

Clinical Affairs & Regulatory Strategies

Regulatory Strategies and Developments

Biologics & Biosimilars

Global Regulatory Intelligence

Regulatory Communications and Submissions

Marketing Authorizations

Regulatory Requirements for Pharmaceuticals

Regulatory Challenges for Medical Devices

Medical Device & Combination Products Regulations

Best Industry Practices

Intellectual Property Rights

Regulatory Affairs 2017 was moderated by Stephen F. Amato, (North Eastern University, Boston, USA)

We are thankful to our below Honourable guests for their generous support and suggestions.

  • Michael Drues- Vascular Sciences, USA
  • Eliana Silva de Moraes– ABPVS, Brazil

The conference proceedings were carried out through various Scientific-sessions and plenary lectures of which the following topics were highlighted as Keynote-presentations:

  • Conducting effective FDA pre-sub meetings: Tell don’t ask... lead don’t follow!: Michael Drues- Vascular Sciences, USA
  • Global regulatory challenges and implicationsEliana Silva de Moraes– ABPVS, Brazil
  • Convergence of regulatory affairs and reimbursement/market Access, Stephen F. Amato, North Eastern University, USA.

Various sessions were chaired and co-chaired by: Eliana Silva de Moraes - ABPVS, Brazil; Diadelis Remirez Figueredo, Devices and medical equipments (CECMED), Cuba; Stephen F Amato, North Eastern University, USA;

Conference Series LLC has taken the privilege of felicitating Regulatory Affairs 2017 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Regulatory Affairs 2017. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Pharmaceutical Regulatory Affairs: Open Access as a special issue.

 

 



Expert Presentations
Eliana Silva de Moraes

ABPVS

Brazil
Michael Drues

Vascular Sciences

USA
Stephen F Amato

North Eastern University

USA
Diadelis Remirez Figueredo

Devices and medical equipments (CECMED)

Cuba
Yavuz S. Silay

Istanbul Consulting Grouop

USA
R C Jagessar

University of Guyana

Guyana
Parminder Kaur

RegPak BioPharma Consulting

Netherlands
Azhar H Alostad

The University of Manchester

UK
Young Kee Shin

Seoul National University

Korea
Rashid Mahmood

Surge Laboratories Private Limited

Pakistan
Muhammad Naeem

Indus Pharma (Pvt.) Ltd

Pakistan
Hanaa A M Elgailany,

Sudan University of Science and Technology

Sudan
Farah Khalil Yousef

Damascus University

Syria
Lisette Pérez Ojeda

CECMED

Cuba
Olorunfunmi

Bingham University

Nigeria
Conference: Regulatory Affairs 2017, Conference Series Conferences
35 Ruddlesway, Windsor,Berkshire, SL4 5SF
Contact: regulatoryaffairs@pharmaconferenceseries.com
Toll free: 0044-2033180199(USA & Canada),
0044-2033180199(Australia), 0044-2033180199(Europe)
Operated by: Editors - Pharmaceutical Regulatory Affairs: Open Access, Pharmacoeconomics: Open Access and Advances in Pharmacoepidemiology & Drug Safety
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2023 Conference Series - All rights reserved